Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrent Squamous Cell Lung Carcinoma 3 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Solid Malignancies 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Cancer Metastatic 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Advanced Rare Tumours 1

Interventions

tremelimumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Squamous Non-small Cell Lung Cancer × durvalumab × Clear all

NCT03319316 2022-01-10

SOLUTION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡